The report linked the shortage of ADHD drugs in the United States to disruptions in the global supply chain
A nationwide shortage of stimulant drugs used to treat attention deficit hyperactivity disorder (ADHD) may have less roots in prescribing practices or federal manufacturing quotas than in global supply chain disruptions. analysis Released late last week JAMA Health Forum. The study, led by researchers at Yale University, looked at possible reasons for the U.S. stimulus … Read more